Skip to main content
logo
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.810
+0.220 (6.13%)
At close: Aug 24, 2026, 4:00 PM EDT
3.750
-0.060 (-1.57%)
After-hours: Aug 24, 2026, 6:56 PM EDT

Xenetic Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2.48-2.68-3.96-4.13-6.55-5.65
Depreciation & Amortization
----0.030.04
Asset Writedown & Restructuring Costs
----1.79-
Stock-Based Compensation
0.090.060.170.280.510.41
Change in Accounts Payable
-0.010.070.08-0.26-0.350.46
Change in Other Net Operating Assets
0.080.260.890-0.080
Operating Cash Flow
-2.31-2.29-2.82-4.11-4.65-4.74
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sale (Purchase) of Intangibles
-----0.5-
Investing Cash Flow
-----0.5-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
44---11.45
Financing Cash Flow
44---11.45

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1.691.72-2.82-4.11-5.156.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2.31-2.29-2.82-4.11-4.65-4.74
Free Cash Flow Growth
------
Free Cash Flow Margin
-70.93%-76.83%-112.69%-161.98%-272.23%-408.21%
Free Cash Flow Per Share
-1.11-1.34-1.83-2.69-3.27-4.61
Levered Free Cash Flow
-1.17-1.38-2.19-2.85-4.56-2.29
Unlevered Free Cash Flow
-1.17-1.38-2.19-2.85-4.56-2.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.070.330.97-0.26-0.430.46
SEC Filings: 10-K · 10-Q